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Abstract Ubiquitination by HECT E3 enzymes regulates myriad processes, including tumor
suppression, transcription, protein trafficking, and degradation. HECT E3s use a two-step mechanism
to ligate ubiquitin to target proteins. The first step is guided by interactions between the catalytic
HECT domain and the E2∼ubiquitin intermediate, which promote formation of a transient, thioesterbonded HECT∼ubiquitin intermediate. Here we report that the second step of ligation is mediated
by a distinct catalytic architecture established by both the HECT E3 and its covalently linked ubiquitin.
The structure of a chemically trapped proxy for an E3∼ubiquitin-substrate intermediate reveals
three-way interactions between ubiquitin and the bilobal HECT domain orienting the E3∼ubiquitin
thioester bond for ligation, and restricting the location of the substrate-binding domain to prioritize
target lysines for ubiquitination. The data allow visualization of an E2-to-E3-to-substrate ubiquitin
transfer cascade, and show how HECT-specific ubiquitin interactions driving multiple reactions are
repurposed by a major E3 conformational change to promote ligation.
DOI: 10.7554/eLife.00828.001

Introduction
A prevailing mechanism for altering protein function involves post-translational modification by
ubiquitin (Ub) via E1-E2-E3 trienzyme cascades. First, an E1 activating enzyme catalyzes formation of
a transient E2∼Ub intermediate, which is linked by a thioester bond between Ub’s C-terminus and
the catalytic cysteine of an E2 conjugating enzyme (here, ‘∼’ refers to a covalent protein–protein
interaction linked by a thioester, oxyester, or isopeptide bond, ‘-’ refers to a noncovalent interaction,
and ‘x’ refers to a crosslinked complex). E3s subsequently utilize one of two general mechanisms
to adjoin the activated Ub C-terminus with targets. E3s in the RING family promote transfer of Ub’s
C-terminus from the E2 catalytic cysteine to a substrate (Deshaies and Joazeiro, 2009). Notably,
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eLife digest Ubiquitin is a small protein that can be covalently linked to other, ‘target’, proteins
in a cell to influence their behavior. Ubiquitin can be linked to its targets either as single copies or as
polyubiquitin chains in which several ubiquitin molecules are bound end-on-end to each other, with
one end of the chain attached to the target protein. A multi-step cascade involving enzymes known
as E1, E2, and E3 adds ubiquitin to its targets. These enzymes function in a manner like runners in
a relay, with ubiquitin a baton that is passed from E1 to E2 to E3 to the target.
The E3 enzyme is a ligase that catalyzes the formation of a new chemical bond between a ubiquitin
and its target. There are approximately 600 different E3 enzymes in human cells that regulate a wide
variety of target proteins. A major class of E3 enzymes, called HECT E3s, attaches ubiquitin to its
targets in a unique two-step mechanism: the E2 enzymes covalently link a ubiquitin to a HECT E3 to
form a complex that subsequently transfers the ubiquitin to its target protein. The ubiquitin is typically
added to a particular amino acid, lysine, on the target protein, but the details of how HECT E3s
execute this transfer are not well understood. To address this issue, Kamadurai et al. investigate how
Rsp5, a HECT E3 ligase in yeast, attaches ubiquitin to a target protein called Sna3.
All HECT E3s have a domain—the HECT domain—that catalyzes the transfer of ubiquitin to its
target protein. This domain consists of two sub-structures: the C-lobe, which can receive ubiquitin
from E2 and then itself become linked to ubiquitin, and the N-lobe. These lobes were previously
thought to adopt various orientations relative to each other to deliver ubiquitin to sites on different
target proteins (including to multiple lysines on a single target protein). Unexpectedly, Kamadurai
et al. find that in order to transfer the ubiquitin to Sna3, Rsp5 adopts a discrete HECT domain
architecture that creates an active site in which parts of the C-lobe and the N-lobe, which are normally
separated, are brought together with a ubiquitin molecule. This architecture also provides a mechanism
that dictates which substrate lysines can be ubiquitinated based on how accessible they are to this
active site.
The same regions of Rsp5 transfer ubiquitin to targets other than Sna3, suggesting that a uniform
mechanism—which Kamadurai et al. show is conserved in two related human HECT E3 ligases—might
transfer ubiquitin to all its targets. These studies therefore represent a significant step toward
understanding how a major class of E3 enzymes modulates the functions of their targets.
DOI: 10.7554/eLife.00828.002

recent structural studies have revealed how isolated RING domains bind both E2 and Ub to optimally
orient and activate the E2∼Ub intermediate for nucleophilic attack (Dou et al., 2012; Plechanovová
et al., 2012; Pruneda et al., 2012). Many ligases utilize a different mechanism possessing an active
site cysteine participating directly in catalysis via a two-step mechanism. First, Ub is transferred from
an E2∼Ub intermediate to the E3 catalytic cysteine to form a labile, thioester-linked E3∼Ub intermediate.
Second, Ub is transferred from the E3 cysteine to a substrate’s primary amino group, which is typically
from a lysine side-chain. This catalytic mechanism is common to many classes of E3s, including several
effector proteins from bacterial pathogens, the RING-IBR-RING family, and HECT (homologous to
E6AP C-terminus) ligases (Scheffner et al., 1995; Zhang et al., 2006; Rohde et al., 2007; Wenzel
et al., 2011). Despite the importance of thioester-forming E3s, the mechanisms by which Ub is ligated
from an E3 cysteine remain elusive, because at the time of original manuscript submission there were no
structures mimicking an E3∼Ub intermediate, and to date there are none representing an E3∼Ub-substrate
complex.
HECT ligases were among the first family of E3 enzymes to be cloned, and are the best functionally
characterized among the thioester-forming E3s (Huibregtse et al., 1995; Scheffner et al., 1995).
Deregulation of HECT E3-mediated ubiquitination is associated with diseases such as cancers,
neurological disorders, autoimmunity, and hypertension (reviewed in Bernassola et al., 2008; Rotin
and Kumar, 2009; Metzger et al., 2012; Scheffner and Kumar, 2013). Thus, it is important to
understand the mechanisms underlying ubiquitination by E3s in the HECT family.
The common feature of HECT E3s is the ∼40 kDa C-terminal catalytic HECT domain. Isolated
C-terminal HECT catalytic domains are capable of binding E2∼Ub, forming an E3∼Ub intermediate,
and ligating the E3-linked ‘donor’ Ub to a specific lysine on an ‘acceptor’ Ub to build a polyubiquitin
chain (reviewed in Kee and Huibregtse, 2007). Accessory domains upstream of the HECT domain
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recruit specific substrates for Ub ligation. The N-terminal sequences guide the classification of HECT
E3s into different sub-families, the largest of which is the NEDD4-family. NEDD4-family members
share a common domain organization with an N-terminal membrane binding C2 domain, two to four
substrate-binding WW domains, and a C-terminal HECT domain. This modular architecture enables
regulation and interactions (reviewed in Ingham et al., 2004; Kee and Huibregtse, 2007; Rotin and
Kumar, 2009). Substrates often contain recognition sequences that bind directly to one or more WW
domains. For example, PPXY (Pro-Pro-X-Tyr) is one common targeting sequence. Some HECT substrates
are multiprotein complexes, with the PPXY motif and ubiquitination sites located in different polypeptides.
Also, many substrates of NEDD4-family E3s are transmembrane proteins in which the PPXY motif and
ubiquitination sites reside in separate cytosolic segments. Furthermore, some substrates do not bind
directly to NEDD4-family E3s, but are instead recruited by adaptor proteins bearing PPXY-like sequences
(reviewed in Léon and Haguenauer-Tsapis, 2009). In addition, for NEDD4-family E3s, a noncovalent
ubiquitin binding site was discovered in the HECT domain, which promotes polyubiquitination through
poorly understood mechanisms (French et al., 2009; Ogunjimi et al., 2010; Kim et al., 2011; Maspero
et al., 2011).
The catalytic HECT domain consists of an N-lobe that binds E2, a flexible linker, and a C-lobe
containing the active site cysteine (Huang et al., 1999; Verdecia et al., 2003). A prior structure of
an E2∼Ub-HECT intermediate revealed that Ub transfer from an E2 to a NEDD4-family HECT E3 is
directed by noncovalent interactions between the HECT domain N-lobe and E2, and by contacts
between the HECT domain C-lobe and the E2-linked Ub (Kamadurai et al., 2009). A structure
published while the present work was under consideration showed preservation of this HECT domainUb conformation immediately upon generation of the E3∼Ub intermediate (Kamadurai et al., 2009;
Maspero et al., 2013), but raised the question of how the E3∼Ub thioester bond could be directed to
a substrate. Although structural mechanisms underlying Ub ligation from the E3 to a substrate remain
poorly understood, a prevailing model is that numerous different relative orientations of the N- and
C-lobes, manifested in prior crystal structures of HECT domains, enable Ub ligation at spatially distinct
sites associated with polyubiquitination of diverse substrates (Huang et al., 1999; Verdecia et al.,
2003; Ogunjimi et al., 2005). However, to date, this hypothesis has not been experimentally tested,
and how Ub and substrates are positioned into the catalytic domain and how the target lysines are
prioritized after their initial capture remains unknown.
To address the mechanisms of HECT E3-mediated Ub ligation, we studied Rsp5, the single essential
NEDD4-family member from Saccharomyces cerevisiae. Rsp5 is required for proteasomal processing
of a membrane-bound transcription factor (Hoppe et al., 2000). Rsp5 also functions in a multitude of
diverse ubiquitin-dependent pathways including 26S proteasomal degradation of RNA polymerase II,
and mediates proteasome-independent regulation of membrane protein trafficking (reviewed in
Ingham et al., 2004; Kaliszewski and Zoladek, 2008; Rotin and Kumar, 2009). Rsp5 has a typical
NEDD4-family domain structure consisting of a C2 domain, three WW domains, and a HECT domain.
Although the Rsp5 C2 domain is required for regulation of endocytosis, a construct comprising only
the third WW and HECT domains (hereafter referred to as ‘Rsp5WW3-HECT’) is sufficient to support
viability under normal growth conditions (Springael et al., 1999; Hoppe et al., 2000). Rsp5 substrates
are typically modified either by a single Ub (‘monoUb’) or by polyubiquitin chains containing isopeptide
linkages between Lys63 and the C-terminus of the subsequent Ub in the chain (Shih et al., 2003;
Kim and Huibregtse, 2009; Wilson et al., 2012). Several prior studies have suggested that the
Rsp5 substrate Sna3, a small transmembrane protein that undergoes Ub-dependent sorting into the
multivesicular body pathway, would be a good model for studying HECT E3-mediated Ub ligation,
because both the Rsp5-binding sequence and a major ubiquitination site are encompassed in Sna3’s
soluble C-terminal cytoplasmic domain (McNatt et al., 2007; Oestreich et al., 2007; StawieckaMirota et al., 2007; Watson and Bonifacino, 2007; Macdonald et al., 2012). Rsp5 binds via its third
WW domain to a PPXY motif (residues 106–109) in Sna3, and ubiquitinates Sna3 at Lys125 (McNatt
et al., 2007; Oestreich et al., 2007; Stawiecka-Mirota et al., 2007; Watson and Bonifacino, 2007;
Macdonald et al., 2012).
Here we define mechanisms underlying HECT E3-mediated Ub ligation. We report the crystal
structure of a ternary complex in which Rsp5′s active site is simultaneously crosslinked to both Ub’s
C-terminus and Sna3, as well as biochemical, genetic, and molecular modeling experiments. Together,
the data reveal interactions between the HECT domain N-lobe, the HECT domain C-lobe, and its
thioester-linked Ub, establishing a specific architecture for ligation. This conformation both confines
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the selection of target lysines and displays a composite active site wherein both HECT domain lobes
contribute to catalysis of ubiquitin transfer.

Results
A simplified HECT E3 ligation model system
To facilitate biophysical and structural studies, we identified a minimal HECT E3-substrate pair (Figure 1).
For an Rsp5 substrate, we turned to the cytoplasmic domain of Sna3 (hereafter Sna3C), because
peptide-like substrates have proven to be very useful for providing insights into the ubiquitin ligation
mechanisms of other families of E3 ligases. The corresponding minimal region of Rsp5 mediating
Sna3C ubiquitination was identified through deletion mapping using a pulse-chase assay. Briefly, a
thioester-bonded E2∼Ub intermediate was enzymatically generated using E1, the E2 UbcH5B, and a

Figure 1. Rsp5WW3-HECT-Sna3C as a minimal model HECT E3-substrate system to study Ub ligation. (A) Schematic
view of two-step HECT E3 ubiquitination mechanism. First, Ub is transferred from an E2∼Ub intermediate to the
HECT E3 catalytic cysteine (Cys) to form a labile, thioester-linked E3∼Ub intermediate. Second, Ub is transferred
from the E3 Cys to a substrate’s primary amino group, which is typically from a lysine side-chain. Ub can also be a
substrate for the second reaction during polyubiquitination. (B) Schematic views of Rsp5 and Sna3 sequences.
(C) Schematic description of pulse-chase assay. A thioester-bonded E2∼Ub intermediate was enzymatically generated
by mixing E1, the E2 UbcH5B, and a fluorescently labeled version of Ub for 30 min. This ‘pulse’ reaction was quenched
by addition of EDTA. In the ‘chase’, wild-type or deletion mutant versions of Rsp5 were added alongside a synthetic
peptide corresponding to Sna3C. Formation of the Rsp5∼Ub intermediate and the Sna3C∼Ub product were monitored
at the indicated time-points. (D) Imaging of nonreducing SDS-PAGE gels monitoring pulse-chase fluorescent Ub
transfer from E2 to Rsp5 to substrate for the indicated versions of Rsp5, in the absence or presence of Sna3C. Rsp5WW3-HECT
is the minimal version mediating Ub ligation to Sna3C.
DOI: 10.7554/eLife.00828.003
The following figure supplements are available for figure 1:
Figure supplement 1. Mutational data defining Rsp5WW3-HECT as a minimal E3 mediating Ub ligation to Sna3C and
autoubiquitination.
DOI: 10.7554/eLife.00828.004
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fluorescently labeled version of Ub. After quenching formation of the E2∼Ub intermediate, wild-type or
truncation mutant versions of Rsp5 were added alongside a synthetic peptide corresponding to Sna3C.
Formation of the Rsp5∼Ub intermediate and the Sna3C∼Ub product were monitored over time (Figure 1C).
Thioester-linked intermediates were confirmed by their susceptibility to reduction by DTT (Figure 1—figure supplement 1). Complexes in which Ub was linked via an isopeptide bond from autoubiquitination of Rsp5 or ligation to a lysine on Sna3C were not susceptible to reduction. As expected, the
isolated HECT domain forms a thioester-linked intermediate with Ub, but is incapable of promoting
Ub ligation to substrate (Figure 1D, Figure 1—figure supplement 1). Inclusion of the third WW
domain is required for Ub ligation to both Sna3C and also for autoubiquitination of Rsp5 itself (Figure 1D).
Notably, little Rsp5WW3-HECT autoubiquitination is observed in the presence of the excess Sna3C substrate in our assays (Figure 1D).

Alanine scanning mutagenesis of the Rsp5 HECT domain E3 suggests
distinct architectures for E2-to-E3 Ub transfer and ligation
Interlobe flexibility observed upon comparing the structures of isolated HECT domains, and mutagenesis
of residues linking the N- and C-lobes from a HECT domain, led to the idea that the N- and C-lobes
adopt many different relative orientations during polyubiquitination (Huang et al., 1999; Verdecia
et al., 2003; Ogunjimi et al., 2005). In this model, the catalytic requirements for ligation are encompassed exclusively in the C-lobe, its thioester-linked Ub, and the substrate. We considered that alternatively, tethering between the HECT domain N- and C-lobes could specify a limited set of distinct
conformations for forming the thioester-linked E3∼Ub intermediate and for ligation. To distinguish
between these mechanisms, we performed comprehensive alanine mutagenesis of the HECT domain
in Rsp5WW3-HECT. We examined pulse-chase Ub ligation by 65 Rsp5WW3-HECT variants, each with one to four
alanine mutations in the HECT domain (180 surface residues mutated in total) (Figure 2A, Figure 2—
figure supplement 1). The rates of Ub transfer to Rsp5WW3-HECT’s cysteine and subsequent ligation to
the Sna3C peptide were too rapid to observe the thioester-linked E3∼Ub intermediate at the earliest
time-point in this assay. Thus, we considered that mutants displaying persistence of the E2∼Ub
intermediate would identify residues important for Ub transfer from E2 to the HECT domain. We
anticipated that these mutations would map to the N- and C-lobe surfaces shown to bind E2∼Ub in the
prior crystal structure of a trapped E2∼Ub-HECT complex (Kamadurai et al., 2009). By contrast, mutants
displaying accumulation of the Rsp5WW3-HECT∼Ub intermediate would indicate defective ligation. We
hypothesized that if the HECT domain adopts a specific architecture for ligation, then some mutations
in the N-lobe may also hinder ligation. Alternatively, if the two HECT domain lobes are flexibly tethered
during ligation, we expected that mutations disrupting Ub transfer to Sna3C would map to the C-lobe,
where Ub is linked. Results from the Ala scan revealed that mutations defective in the first catalytic
step of E2-to-E3 transfer all map to the E2∼Ub binding site and the N-lobe/C-lobe interface identified
in the previous E2∼Ub-HECT domain structure (Figure 2B). By contrast, mutants that hindered Ub
ligation to Sna3C map to distinctive surfaces on the N- and C-lobes (Figure 2B). Thus, the mutational
data suggest a specific HECT domain architecture may be important for Ub ligation to Sna3C, and
this conformation would involve both the catalytic C-lobe and the distal N-lobe packing differently
from the arrangement promoting ubiquitin transfer from E2-to-E3.

Crystal structure of a trapped Rsp5WW3-HECT complex with Ub and Sna3C
as a proxy for the catalytic intermediate
To visualize the Rsp5WW3-HECT architecture mediating ligation, we devised a method to bypass the instability of an Rsp5∼Ub thioester bond, allowing generation of a stable proxy for a HECT E3∼Ub-substrate
intermediate. A synthetic Sna3C peptide with the acceptor Lys125 substituted with azidohomoalanine
was linked by Click chemistry to a homobifunctional maleimide crosslinker (Figure 3A,B). One arm was
crosslinked to Rsp5WW3-HECT, and the other to a Cys side-chain substituted for Gly75 of Ub. This enabled
us to determine the crystal structure of Rsp5WW3-HECT with the active site cysteine (Cys777) simultaneously
crosslinked to the C-terminus of the Ub variant and to Sna3C (Rsp5WW3-HECTxUbxSna3C) (Figure 3C,
Figure 3—figure supplement 1). The crystals contained two Rsp5WW3-HECTxUbxSna3C complexes per
asymmetric unit, which superimpose with ∼0.5 Å RMSD. Accordingly, only one is discussed here. The
individual domains in Rsp5WW3-HECTxUbxSna3C overlay well with previous HECT structures. Noncovalent
interactions between the HECT domain C-lobe and Ub involved in Ub transfer from E2-to-E3
(Kamadurai et al., 2009; Maspero et al., 2013) are preserved in the Rsp5WW3-HECTxUbxSna3C structure.
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Figure 2. Alanine scanning mutagenesis suggests distinct specific HECT domain architectures to receive and ligate ubiquitin. (A) Summary of effects of
indicated HECT domain Ala mutations on pulse-chase fluorescent Ub transfer from E2 to Rsp5WW3-HECT and then from Rsp5WW3-HECT to Sna3C. The assay
scheme is shown in Figure 1C, except a 15 s chase was used. Cyan bars—accumulation of thioester-linked E2∼Ub intermediate, reflecting a defect in Ub
transfer from E2 to E3. Purple bars—accumulation of thioester-linked E3∼Ub intermediate, reflecting a defect in Ub transfer from E3 to substrate. Green
bars—ratio of Sna3C∼Ub product formed. Standard deviations are calculated from three independent replications. (B) Locations of mutations hindering
E2-to-Rsp5WW3-HECT (blue) or Rsp5WW3-HECT-to-substrate (green) Ub transfer mapped on prior E2∼Ub-HECT domain structure (Kamadurai et al., 2009).
Magenta surfaces represent residues mutated and found not essential for activity.
DOI: 10.7554/eLife.00828.005
The following figure supplements are available for figure 2:
Figure supplement 1. Representative raw data from Ala scan.
DOI: 10.7554/eLife.00828.006

The Sna3C PPXY motif binds Rsp5′s WW3 domain in a typical manner (Vijay-Kumar et al., 1987; Kanelis
et al., 2001; Kim et al., 2011). However, the overall Rsp5WW3-HECTxUbxSna3C assembly is distinctive, with
the HECT domain active site and its covalently linked Ub facing the Sna3C substrate (Figure 3C).
Importantly, the locations of the HECT domain Ala scan mutations that selectively impaired ligation map
to surfaces that anchor the Rsp5 lobes and Ub in the Rsp5WW3-HECTxUbxSna3C structure (Figure 3D).
The HECT domain∼Ub architecture is established by extensive interactions that bury ∼2800 Å of
surface area between the N- and C-lobes, and Ub. Below we describe how (1) the two lobes of the
HECT domain cradle Ub’s C-terminus to prime the thioester bond for the ligation reaction, (2) the
HECT domain conformation is established by interactions between the C- and N-lobes, (3) the HECT
domain architecture results in a composite Ub/N-lobe/C-lobe catalytic center, with critical N-lobe
residues placed adjacent to Ub’s thioester linkage to the catalytic Cys in the C-lobe, (4) the catalytic
architecture projects the E3∼Ub thioester bond toward the substrate and prioritizes substrate lysines
for ubiquitination, and (5) together with the prior structure of a trapped E2∼Ub-HECT intermediate
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Figure 3. Structure of a trapped proxy for an Rsp5∼Ub-Sna3C intermediate. (A) Chemical representation of substrate
lysine attack of an Rsp5∼Ub thioester bond. (B) Chemical representation of the trapped proxy, depicting covalent
bonds linking Rsp5 Cys777, a Ub Cys75 (in place of Gly75-Gly76) and Sna3C Cys125 (in place of Lys125) in
Rsp5WW3-HECTxUbxSna3C complex. (C) Three views of Rsp5WW3-HECT (violet) xUb (yellow) xSna3C (green), with catalytic
Cys shown as orange sphere. Regions not observed in electron density are indicated with dashed lines.
(D) Locations of Ala scan mutations hindering E2-to-Rsp5WW3-HECT (blue) or Rsp5WW3-HECT-to-substrate (green) Ub
transfer mapped on Rsp5WW3-HECTxUbxSna3C structure.
DOI: 10.7554/eLife.00828.007
The following figure supplements are available for figure 3:
Figure supplement 1. Electron density for Rsp5WW3-HECTxUbxSna3C structure.
DOI: 10.7554/eLife.00828.008

(Kamadurai et al., 2009) the new data rationalize the necessity for rotation about the HECT domain
N- and C-lobes by enabling visualization of a HECT E3 Ub transfer cascade.

The Ub~HECT covalent linkage is oriented by Ub interactions with the
HECT domain N- and C-lobes
The HECT domain architecture in the Rsp5WW3-HECTxUbxSna3C structure results in Ub being sandwiched
between the C- and N-lobes (Figure 4A). On one side, the interface between Ub’s globular domain and
the HECT C-lobe superimposes with the corresponding region of the E2∼Ub-HECT structure (0.99 Å
RMSD) (Figure 4B). Here, Ub’s Ile36/Gln40/Leu71/Leu73 hydrophobic patch contacts Leu771, Leu798,
Ala799, Glu802, and Thr803 of Rsp5 (Figure 4C,D). Accordingly, mutating these interface residues of Ub is
lethal to yeast (Sloper-Mould et al., 2001; Kamadurai et al., 2009), and Ub transfer from E2 is impaired
for L771A/L798A and E802A/T803A/I804A mutant versions of Rsp5WW3-HECT tested in our Ala scan, and for
the L73A mutant versions of Ub (Figures 2A and 4E). The E3∼Ub intermediate accumulates and the rate
of Ub ligation to Sna3C is also slowed for these mutants, although a relatively lesser effect on Rsp5-mediated
Ub ligation to substrate may reflect the larger interface stabilizing E3–Ub interactions for the second
reaction step (Figure 4E). Neither Ub transfer from E2 to Rsp5WW3-HECT nor from Rsp5WW3-HECT to Sna3C
is substantially affected by an Ala substitution for Ub’s Ile44, which does not make contacts in either the
prior E2∼Ub–NEDD4LHECT or the current Rsp5WW3-HECTxUbxSna3C structures (Figure 4E). Conversely, Ile44 is
essential for RING E3-mediated Ub ligation and for E3-independent polyubiquitination by some E2s (Saha
et al., 2011; Wickliffe et al., 2011; Dou et al., 2012; Plechanovova et al., 2012; Pruneda et al., 2012).
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Figure 4. HECT domain–Ub interactions for ligation. (A) Ub’s C-terminal tail and its covalent linkage to the Rsp5 catalytic Cys are shown sandwiched between
the Rsp5 N- and C-lobes in the crystal structure of Rsp5WW3-HECT (violet) xUb (yellow) xSna3C (not shown). (B) C-lobe-Ub portions superimposed for Rsp5WW3-HECT
(violet) xUb (yellow) xSna3C (not shown) and E2 (not shown)∼Ub (orange)-NEDD4LHECT (blue) (Kamadurai et al., 2009). (C) Close-up view of interactions between
Rsp5 C-lobe and the C-terminal tail of covalently linked Ub in the crystal structure of Rsp5WW3-HECT (violet) xUb (yellow) xSna3C (not shown). (D) Close-up
view of interactions between NEDD4L C-lobe and the C-terminal tail of the E2-linked Ub in the crystal structure of E2 (only the Cys-to-Ser mutation at the active
site is shown) ∼Ub (orange)-NEDD4LHECT (blue) (Kamadurai et al., 2009). (E) Nonreducing gels from pulse-chase E2-to-Rsp5-to-Sna3C Ub transfer assay, using
indicated versions of Rsp5WW3-HECT and of fluorescent or radioactive Ub. Bands corresponding to thioester-linked E2∼Ub and Rsp5WW3-HECT∼Ub intermediates
and isopeptide-bonded Sna3C∼Ub product are indicated. (F) Yeast complementation assays for the indicated HA-Rsp5 mutants.
DOI: 10.7554/eLife.00828.009

The Ub C-terminal tail adopts an extended conformation, secured through an intermolecular
β-sheet with the HECT β-strand leading to the covalent linkage with the catalytic Cys777 (Figure 4C).
Here, backbone hydrogen bonds are formed between Ub residues 73 and 75 and Rsp5′s Ser774.
Because this three-residue β-sheet is not found when Ub is bound to E2 in the E2∼Ub-HECT complex
(Kamadurai et al., 2009), this structure apparently results from covalent linkage to the E3 Cys, and is
likely specific for ligation (Figure 4C,D).
Three-way interactions between the HECT domain N-lobe, C-lobe, and the covalently linked Ub are
anchored by Ub’s Arg74 (Figure 4C). The aliphatic portion of Ub’s Arg74 interacts with Phe736 from
Rsp5′s C-lobe. On the other face of Ub, the Arg74 guanidino group packs in a region of the N-lobe
dominated by acidic residues, and directly contacts Glu502, which corresponds to a site of mutation
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in the E6AP HECT E3 in Angelman syndrome (Huang et al., 1999; Cooper et al., 2004). Mutation
of Arg74 in Ub or Glu502 in the Rsp5 HECT domain N-lobe impaired Ub ligation to Sna3C in vitro
(Figure 4E), and Rsp5′s essential function in vivo (Figure 4F) (Sloper-Mould et al., 2001). Through
rapid quench-flow kinetic analyses, we measured a sevenfold defect in the rate of Ub transfer from
Rsp5WW3-HECT to Sna3C for the E502A mutant in our assay (Figure 5).

Interlobe interactions stabilize HECT domain conformation
In the Rsp5WW3-HECTxUbxSna3C structure, almost half the N-lobe nestles and orients the C-lobe (Figure 5A).
Notably, the importance of these N-lobe/C-lobe interactions is confirmed by impaired ligation activity
for every Ala scan mutant mapping to this interface (Figures 2A and 3D). For example, Arg560 and

Figure 5. Ala mutations selectively impaired for ligation map to N-lobe/C-lobe interface in Rsp5WW3-HECTxUbxSna3C
crystal structure. (A) Rsp5WW3-HECTxUbxSna3C crystal structure highlighting locations of Ala mutants (sticks, colored by
mutant as indicated) selectively impaired for ligation. Dotted line indicates approximate locations of mutations in
the N-lobe not visible in electron density. (B) Close-up views highlighting N-lobe/C-lobe interface locations of Ala
mutants selectively impaired for ligation. Dotted line indicates approximate locations of mutations in the N-lobe
not visible in electron density. (C) Initial rates of fluorescent Ub transfer from E2 to the indicated versions of Rsp5WW3-HECT
measured in rapid quench-flow pulse-chase assays. (D) Initial rates of fluorescent Ub transfer from the indicated
versions of Rsp5WW3-HECT to Sna3C measured in rapid quench-flow pulse-chase assays. (E) Fluorescent images of
nonreducing SDS-PAGE gels showing rapid-quench flow pulse-chase fluorescent Ub transfer from E2 to Rsp5WW3-HECT
to Sna3C, for the indicated versions of Rsp5WW3-HECT. Bands corresponding to thioester-linked E2∼Ub and Rsp5WW3-HECT∼Ub
intermediates and isopeptide-bonded Sna3C∼Ub product are indicated.
DOI: 10.7554/eLife.00828.010
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Phe561 from the N-lobe map to the core of the interface with the C-lobe (Figure 5B). Accordingly,
the Arg559, Arg560, Phe561 triple Ala mutant was severely impaired in Ub ligation to Sna3C, with
no defect in the rate of E2-to-Rsp5 Ub transfer in our assay (Figure 5C–E). Similarly, Arg501 from the
N-lobe further anchors the C-lobe, and the combination of R501A and E502A mutations completely
abrogates ligation in our assay, with a more severe defect than E502A alone (Figure 5B–E). There are
lesser effects of mutating side-chains in the Lys432/Arg433/Asp434/Arg436 and Arg437/Lys438/
Ile440/Tyr441 combinations in the N-lobe, and the Val745/Asn746/Lys749/Asp750 combination in
the C-lobe, presumably because of their more peripheral locations in the interdomain interface
(Figure 5A).
Furthermore, the C-lobe’s Phe806, also known as the ‘-4 phenylalanine’ required for the polyubiquitination cycle (Salvat et al., 2004), loosely approaches Phe505 and Leu506 in the N-lobe (Figure 6A).
The F806A mutant was severely impaired in the Ala scan, and pulse-chase assays show specific defects
in Ub ligation upon mutating either Rsp5WW3-HECT’s Phe806 to Leu, or the Phe505 and Leu506 from the

Figure 6. HECT domain C-lobe/N-lobe interactions anchoring architecture for ligation. (A) Close-up view of a portion of the C-lobe/N-lobe interface in
Rsp5WW3-HECTxUbxSna3C structure. (B,C) Nonreducing gels from pulse-chase transfer assay of fluorescent Ub from E2-to-Rsp5-to-Sna3C using indicated
mutants of Rsp5. Bands corresponding to thioester-linked E2∼Ub and Rsp5WW3-HECT∼Ub intermediates and isopeptide-bonded Sna3C∼Ub product are
indicated. (D) Left: HA-tagged WT and mutant rsp5 alleles housed on low copy plasmids were assessed for their ability to complement the essential
function of RSP5 in either serially diluted rsp5-1 temperature-sensitive cells grown at restrictive 37°C or in rsp5Δ null cells after eviction of wild-type RSP5
plasmid on 5-FOA. Below: whole cell lysates of rsp5-1 transformants immunoblotted for HA and PGK. (E) Rates of pulse-chase fluorescent Ub ligation from
the indicated versions of Rsp5WW3-HECT to Sna3C.
DOI: 10.7554/eLife.00828.011
The following figure supplements are available for figure 6:
Figure supplement 1. A role for HECT domain C-terminus in ligation.
DOI: 10.7554/eLife.00828.012
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N-lobe simultaneously to aspartates (Figures 2A and 6B). Leu506 is adjacent to Arg461, and a bulky
R461F mutation also hinders ligation (Figure 6B). In agreement with the structural data, these mutations
are ligation-specific, and do not impact formation of the thioester-linked Rsp5WW3-HECT∼Ub intermediate.
We devised an experiment to dissect the role of the -4 Phe during ligation, by complementing the
defect of the C-lobe F806L with a compensatory aromatic residue at position 506 of the N-lobe. Indeed,
the defect from the F806L mutation in the C-lobe is largely ameliorated by complementary N-lobe
L506W or L506F mutations both in vivo and in vitro (Figure 6A,C–E). Moreover, rapid quench-flow
kinetic analyses confirmed wild-type rates of E2-to-E3 Ub transfer for these mutants, and also observed
43-fold rescue in the rate of Ub ligation to Sna3C when the defective F806L mutant was combined with
L506F mutation (Figure 6E). This compensation is selective, as L506F does not influence the deleterious
effects of mutating the structurally distal residue Phe778, even after extended reaction times. Overall,
these data demonstrate that an aromatic side-chain has a critical function in the ligation reaction
by anchoring the two HECT domain lobes.

A functional role for Rsp5′s C-terminus
Because Phe806 is near to the C-terminus, we considered whether the Rsp5 C-terminal sequence
may play a role in ligation. Deleting Rsp5′s C-terminal residue severely impairs Ub ligation to Sna3C,
although not to the same extent as the extremely deleterious D495A mutant identified in our Ala
scan (Figure 6—figure supplement 1A,B). Our results are consistent with the recent finding that
deleting Rsp5′s C-terminal residue also impairs substrate-independent polyubiquitination by the
isolated HECT domain from Rsp5 (Maspero et al., 2013). However, although it has been suggested
that a C-terminal acidic side-chain may perform a catalytic role in the ligation reaction (Maspero et al.,
2013), we observed no defect upon simultaneously mutating all three of Rsp5′s C-terminal residues to
alanines (Figure 2A), or mutating the Rsp5′s C-terminal residue to Arg (Figure 6—figure supplement 1A).
Future studies will be required to definitively determine the role of the C-terminus, which has not been
observed in any structure of a HECT E3, including Rsp5WW3-HECTxUbxSna3C. However, we speculate that for
Rsp5 and possibly other HECT E3s, the C-terminus itself may contribute to the ligation reaction. Indeed,
C-terminal epitope tags have been shown to hinder activity (Salvat et al., 2004). Alternatively, the
C-terminus may stabilize the conformation of the HECT∼Ub complex. In this regard, we note that in
the Rsp5WW3-HECTxUbxSna3C structure, the backbone amides from Leu73 and Arg74 and other portions of
Ub’s extended C-terminal tail are partially exposed and could potentially interact with the acidic C-terminus
of the HECT domain (Figure 6—figure supplement 1C).

A composite HECT domain catalytic center involving both the HECT C- and
N-lobes
To generate models for the substrate lysine and a functionally important N-lobe loop not visible in the
Rsp5WW3-HECTxUbxSna3C electron density, we used the structure prediction program Rosetta. First, we
determined the orientation of the thioesterified ubiquitin tail using constraints on the ubiquitin
locations derived from the crystal structure. To accommodate the ubiquitin location, the catalytic
cysteine must adopt the gauche+ rotamer, which allows formation of the thioester and its packing
against His775, Thr776, and the noncovalent interactions between Ub and the Rsp5 C-lobe (Figure 7A).
Given the geometric requirements for isopeptide bond formation, this rotameric preference directs
the acceptor lysine’s path of attack and all models predicted that Lys125 of Sna3 packs against Phe778
(Figure 7B). His775, Thr776, and Phe778 correspond to residues that also interact with E2∼Ub during
formation of the HECT E3∼Ub intermediate (Kamadurai et al., 2009). Their interaction with Ub was
recently also observed in the structure of a HECT E3∼Ub intermediate published while our manuscript
was under consideration (Maspero et al., 2013). Furthermore, H775A and T776A mutations result
in modest defects in Ub ligation to Sna3C, and an F778A mutation results in a more severe defect
(Figure 7C). While all the models demonstrate a similar approach for Sna3 Lys125, modeling the
additional residues between this Lys125 and the PPXY motif revealed multiple orientations that could
accommodate a proper Lys125 active-site approach. Accordingly, neither Ala nor Glu substitutions
adjacent to the acceptor lysine influenced substrate selection (Figure 7—figure supplement 1).
Although the Rsp5 loop comprising residues 491–495 is not visible in the structure, our Ala scan
results revealed that Glu491 and Asp495 are essential for the ligation reaction, and defective ligation
was also observed for the L494A Y496A double mutant (Figure 2A). Accordingly, E491A and D495A
Rsp5 mutants are also defective in supporting yeast growth (Figure 7D). To gain initial insights
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Figure 7. A distinctive active site for HECT E3-mediated ligation. (A) Rosetta-generated models for Sna3C (different models in different shades of green) target
lysine approaching Rsp5WW3-HECT (violet) active site Cys777 thioester-linked to Ub (yellow). (B) Model for residues aligning thioester-bound Ub and Sna3C acceptor
lysine approaching the active site. (C) Nonreducing gels from pulse-chase assay for transfer of fluorescent Ub from E2-to-Rsp5-to-Sna3C using indicated versions
of Rsp5WW3-HECT. Bands corresponding to thioester-linked E2∼Ub and Rsp5WW3-HECT∼Ub intermediates and isopeptide-bonded Sna3C∼Ub product are indicated.
(D) Yeast complementation assays for the indicated HA-Rsp5 mutants. (E) Close-up of structural superposition of N-lobes showing catalytic loop from
NEDD4LHECT (Kamadurai et al., 2009) not visible in Rsp5WW3-HECT (violet) structure.
DOI: 10.7554/eLife.00828.013
The following figure supplements are available for figure 7:
Figure supplement 1. Residues proximal to the acceptor lysine in Sna3 play insignificant roles in ubiquitination.
DOI: 10.7554/eLife.00828.014

into potential functions of this region, we superimposed the structure of the HECT domain N-lobe
from NEDD4L (Kamadurai et al., 2009) onto Rsp5WW3-HECTxUbxSna3C (Figure 7E). This suggested that
the 491–495 loop from the N-lobe is located adjacent to the thioester bond between Ub and the catalytic Cys in the C-lobe, and provides a rationale for the importance of the HECT domain architecture
for the ligation reaction. Structural modeling of this critical N-lobe loop using Rosetta suggests that
Glu491 could contribute to positioning the loop and may participate in an electrostatic network involving
Arg74 of Ub and Arg461 of Rsp5 (Figure 7B). Furthermore, these structural models demonstrate that
the acidic loop can adopt several permissive orientations that allow the carboxyl group of Asp495 to
approach the epsilon nitrogen of the acceptor lysine (Figure 7B). Asp495 may activate ubiquitin ligation
through a variety of mechanisms including guiding the lysine into the active site or by contributing,
either directly or indirectly, to the deprotonation of the substrate lysine. Direct deprotonation may be
less likely as we were unable to rescue catalytic activity either with a D495H mutant, or chemically by
adding high concentrations of formate or acetate (Figure 7D and data not shown).

General importance of architecture for HECT E3-mediated Ub ligation
We wished to address whether the catalytic conformation is specific for Sna3C and Rsp5, or whether
there is a general NEDD4-family HECT E3 architecture for ligation. As a first test, we sought to
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examine the effects of alanine substitutions on another Rsp5 substrate. As NEDD4-family HECT E3s
can transfer Ub to a free Ub acceptor, we tested the effects of mutations on di-Ub synthesis. There is
a striking similarity in the effects of the Ala mutations in pulse-chase assays for Ub ligation to Sna3C and
to free Ub as the substrate (Figure 8). Some subtle differences appear due to the high concentration
of free Ub ameliorating the deleterious effects of a few mutations on E2-to-E3 Ub transfer, potentially
due to Ub’s noncovalent association with the HECT domain N-lobe stabilizing the E2 binding site.
Also, one mutant (L494A, Y496A) showed a greater defect in di-Ub synthesis, perhaps marking the site
where Ub binds as a substrate. Nonetheless, the overall agreement between mutational effects on
modification of the two distinctive substrates suggests that a specific HECT domain architecture is
generally important for Rsp5-mediated Ub ligation.
As a first step toward testing whether other HECT E3s adopt a similar architecture for ligation,
we examined whether other NEDD4-family HECT E3s showed defects upon mutating their N-lobe
aspartate corresponding to Rsp5′s Asp495, which is distal from the catalytic center for Ub transfer
from E2 to NEDD4-family E3s (Kamadurai et al., 2009), but maps to the composite active site for
ligation (Figure 9). As with the Rsp5WW1-3-HECT D495A mutant, the corresponding D584A and D639A
mutant versions of NEDD4WW1-4-HECT and NEDD4LWW1,3-4-HECT form an E3∼Ub thioester intermediate.
However, the mutations completely eliminate autoubiquitination. Taken together, the results raise the
possibility that NEDD4-family HECT E3s use a common, specific catalytic architecture for Ub ligation
to various substrates.

The catalytic architecture provides a mechanism for target lysine selection
A fundamental question is how substrate lysines are selected for ubiquitination. A mechanism
for prioritizing lysines for modification is suggested by the ligation-primed architecture of the

Figure 8. Ala scan for HECT domain surfaces required for di-Ub synthesis. (A) Summary of the effects of indicated Rsp5WW3-HECT HECT domain Ala mutations on
pulse-chase fluorescent Ub transfer from E2 to Rsp5WW3-HECT and then to Ub. Total activity within each gel lane was determined by adding all intensities for all
three species (E2∼Ub, Rsp5WW3-HECT∼Ub, and Ub∼Ub) and was used to estimate the relative yield of each with respect to wild-type proteins. The error bar shows
the standard deviation (SD) for three independent replicates. (B) Fluorescent imaging of representative nonreducing (left) and reducing (right) gels from assays
used for data in A, monitoring pulse-chase fluorescent Ub transfer from E2 to the indicated versions of Rsp5WW3-HECT to Ub. The chase was 15 s.
DOI: 10.7554/eLife.00828.015
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Figure 9. Key residues for ligation are conserved across HECT E3s. (A) Alignment of portions of sequence from
Rsp5 with corresponding regions of human NEDD4L, NEDD4, Smurf1, Smurf2, WWP1, WWP2, ITCH, NEDL1,
NEDL2, and E6AP showing conservation of key residues establishing the ligation mechanism. Identity to Rsp5
sequence is highlighted in yellow. (B) Fluorescent images of nonreducing (left) and reducing (right) gels of multiple
turnover autoubiquitination assays for wild-type and the indicated Asp-to-Ala mutant versions of NEDD4WW1-4-HECT,
NEDD4L1-3-4-HECT, and Rsp5WW1-3-HECT.
DOI: 10.7554/eLife.00828.016

Rsp5WW3-HECTxUbxSna3C complex. In the structure, Ub’s C-terminus and the E3 catalytic Cys face the
C-terminus of the substrate’s PPXY motif anchored to the WW3 domain. However, the N-terminus of
the bound Sna3C substrate is distal, and points away from the HECT domain active site.
We considered that the relative positions of the substrate-binding WW3 domain and the HECT domain
N- and C-lobes might influence sites of Ub modification. In the structure, ∼25 Å separates the HECT domain
active site and the Sna3C PPXY motif. The distance predicts a requirement for a 10-residue spacer between
the PPXY motif that binds the WW3 domain and the acceptor lysine that receives Ub from the HECT
cysteine (Figure 10). By contrast, according to prior models suggesting that the domains are flexibly
tethered during ligation, it would be possible to juxtapose the catalytic cysteine in the HECT domain
C-lobe with a substrate lysine only two residues C-terminal of the WW3-bound PPXY motif in Sna3C (VijayKumar et al., 1987; Kanelis et al., 2001; Kim et al., 2011). Thus, as a further test of the relevance of
the fixed HECT domain architecture for ligation, we developed an assay for target lysine selectivity,
using a TEV-cleavable HisMBP-fusion to Sna3C as a substrate. Fluorescent Ub∼E2 was added to a mixture
of Rsp5WW1-3-HECT and HisMBP-TEV-Sna3C, and Ub transfer was terminated by adding DTT to reduce
thioester-linked intermediates. After treatment with TEV protease, the levels of fluorescent Ub-ligated
Sna3C, HisMBP, and autoubiquitinated Rsp5WW1-3-HECT were compared (Figure 10B, Figure 10—figure
supplement 1). For wild-type HisMBP-TEV-Sna3C, Ub is predominantly ligated to Sna3C. Without HisMBPTEV-Sna3C, or with a mutant disrupting the HisMBP-TEV-Sna3C PPXY motif, Ub is ligated to Rsp5WW1-3-HECT
itself. Conversely, if a HisMBP-TEV-Sna3C with a K125A mutation that eliminates Sna3 ubiquitination but still
retains its Rsp5-binding PPXY motif is used, Ub is ligated to both HisMBP and Rsp5WW1-3-HECT. Therefore,
the distribution of Ub-ligated Sna3C, HisMBP, and Rsp5WW1-3-HECT products distinguishes preferences among
different Ub-accepting lysines on substrates recruited via the same PPXY motif (Sna3C vs HisMBP), and on
Rsp5WW1-3-HECT autoubiquitination as an internal control for ligation activity. To test whether the relative
position of a lysine influences its ubiquitination, we performed assays with insertion and deletion mutants
in the 15-residue linker between the PPXY motif and Ub-acceptor lysine of Sna3C. While substrates were

Kamadurai et al. eLife 2013;2:e00828. DOI: 10.7554/eLife.00828

14 of 26

Research article

Biochemistry | Biophysics and structural biology

Figure 10. HECT domain architecture for ubiquitin ligation suggests mechanism for substrate lysine prioritization. (A) Structure of Rsp5WW3-HECT (violet)
xUb (yellow) xSna3C (green), highlighting 25 Å distance between the alpha carbon of Sna3C Tyr109 in the PPXY motif and the sulfur of Rsp5WW3-HECT
Cys777. (B) Schematic view of substrate selection assay. (C) Rsp5WW1-3-HECT selection between substrates with relative distributions of non-reducible
Sna3C∼Ub (green bar graph), autoubiquitinated Rsp5WW1-3-HECT∼Ub (violet bar graph), and HisMBP∼Ub (gray bar graph) products of reactions with
substrates bearing the indicated number of residues between the Sna3C PPXY motif and lysine. Effects of Ala mutations in place of the Sna3C acceptor
Lys125 and the WW3-binding Pro107 are shown as controls.
DOI: 10.7554/eLife.00828.017
The following figure supplements are available for figure 10:
Figure supplement 1. Data supporting Rsp5WW3-HECT target Lys prioritization.
DOI: 10.7554/eLife.00828.018

generally tolerant of insertions, reducing the linker to nine residues, irrespective of the sequence
location, dramatically decreased Sna3C ubiquitination while increasing ubiquitination of HisMBP and
Rsp5WW1-3-HECT. The strong spatial preference for target lysines suggests that the Rsp5 domains are not
freely rotating during ligation. Furthermore, the sharp decline in ubiquitination upon reducing the
number of residues linking the Ub acceptor lysine below 10 strongly correlates with the distance
between the C-terminus of the Sna3C PPXY motif and the Rsp5 active site in the Rsp5WW3-HECTxUbxSna3C
structure. Importantly, the N-terminally fused HisMBP was inefficiently ubiquitinated, despite containing 36 lysines. Nor was a lysine placed N-terminal to the PPXY motif. Overall, poor ubiquitination
correlated with the structural location of the N-terminus of the PPXY motif, which projects away from
the active site, although there may also be some context dependence to substrate selection based on
the low activity toward an L121K K125A mutant (Figure 10C, Figure 10—figure supplement 1).
These data are also consistent with in vivo data showing that K125 is the major ubiquitination site of
Sna3 and a Sna3-GFP fusion protein, with the GFP moiety undergoing a lower level of ubiquitination
via its 20 lysines (Stawiecka-Mirota et al., 2007). Notably, the minimum required linker also correlates
with the 12-14 residues between the LPXY motif and Ub acceptor lysines in the Rsp5 substrate
Mga2p120 (Bhattacharya et al., 2009). Overall, the data indicate that the HECT E3 architecture
primed for ligation prioritizes potential target lysines by their placement relative to a composite
catalytic center for ubiquitination.
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Discussion
Taken together with a prior crystal structure of an E2∼Ub-HECT domain complex (Kamadurai et al.,
2009), our data allow visualization of a HECT E3’s multistep Ub transfer cascade. Our systematic Ala
scanning mutagenesis (Figure 2) confirms that the previous structure of a complex between
oxyester-linked E2∼Ub and a HECT domain (Kamadurai et al., 2009) explains how Ub is transferred
from E2 to NEDD4-family HECT E3s, wherein the HECT domain C-lobe and catalytic cysteine face
the E2. This position is dictated by noncovalent interactions between the HECT domain N-lobe and the
E2, and between HECT domain C-lobe and the E2-linked Ub (Kamadurai et al., 2009). Our new data
and a study published during manuscript revision (Maspero et al., 2013) suggest that after the
E3∼Ub intermediate is formed, the C-lobe remains associated with its thioester-linked Ub.
Here, to our knowledge, we provide the first snapshot of a HECT E3 poised to transfer Ub, enabled
through our development of a technology for site-specific three-way crosslinking. The crystal structure
of Rsp5 with its active site Cys simultaneously crosslinked to Ub’s C-terminus and to a substrate reveals
that the HECT domain C-lobe and Ub together rotate ∼130° to face the substrate bound to an
N-terminal WW domain (Figure 11). The three-way anchored HECT domain N-lobe/C-lobe∼Ub
architecture would reduce inherent conformational flexibility (Verdecia et al., 2003), and orient the
E3∼Ub intermediate toward the substrate for the ligation reaction (Figure 3). Furthermore, the fixed
architecture for the HECT domain and its thioester-bound Ub during ligation would restrict orientations
available to the WW domain, thus limiting the positions available for a lysine to access the active site.
We anticipate that other E3s functioning via a catalytic cysteine, including several effector proteins
from bacterial pathogens and members of the RING-IBR-RING family (Zhang et al., 2006; Rohde
et al., 2007; Wenzel et al., 2011), also activate Ub ligation through parallel mechanisms that align
their E3∼Ub intermediates. This theme is reflected by how mechanistically unrelated E3s (e.g., a SUMO
E3 in the ‘neither-HECT-nor-RING’ class, and Ub E3s in the RING family) bind both E2 and its thioesterlinked Ub-like protein (Ubl) to reduce conformational heterogeneity and optimally orient the E2∼Ubl
nucleophilic attack (Reverter and Lima, 2005; Pruneda et al., 2011; Dou et al., 2012; Plechanovova
et al., 2012; Pruneda et al., 2012). Nonetheless, there are notable mechanistic differences between
HECT E3s. For example, prior to the ligation reaction, there are differences during Ub transfer from
the E2. For HECT E3s, orientation of the E2∼Ub thioester bond involves extensive interactions between
Ub and its ‘target’—the C-lobe to which Ub will be transferred. By contrast, RING domains apparently
orient the E2∼Ub thioester bond for nucleophilic attack even in the absence of any downstream
acceptor. As a result, RING E3s promote discharge of associated E2∼Ub thioester intermediates,
whereas E2∼Ub complexes are stable in the presence of catalytic Cys mutant versions of HECT domains.
Another mechanistic difference is reflected by exposure of Ub’s Ile44 in HECT E3 intermediates,
whereas for RING and related E3s the enzyme bearing the thioester-bound Ub binds the notorious ‘I44
patch’ on Ub to orient the thioester bond. Thus, different E3 families have evolved distinct approaches
to activate Ub transfer to appropriate targets.
A major question is how lysines are selected for Ub and Ub-like protein modification. To date, this
is best understood for E3-independent interactions between E2s and substrates, including Ub during
polyubiquitination. These include Ubc9 binding a specific SUMO target sequence (Bernier-Villamor et al.,
2002), Ube2S binding an acidic portion of Ub that completes its catalytic site (Wickliffe et al., 2011), and
Ubc13 binding a partner protein that presents a specific Ub target lysine (Eddins et al., 2006). Mechanisms
underlying RING E3 presentation of substrates are generally less understood. For example, different
members of the SCF family of RING E3s appear to utilize distinct selections: context is a major
determinant of target lysines during SCFCdc4-dependent ubiquitination of Sic1 in vivo, (Sadowski et al.,
2010), spatial proximity to the noncovalent binding site is important for in vitro ubiquitination of β-catenin
by un-neddylated SCFβ-TRCP (Wu et al., 2003), and future studies will be required to determine
mechanisms dictating substrate lysine selection by NEDD8-activated SCF E3s. Our data show how a
NEDD4-family HECT E3’s architecture prioritizes lysines recruited to a WW domain by their placement
relative to a composite catalytic center that involves residues from both HECT domain lobes. Although
future studies will be required to reveal how substrates recruited to other domains of HECT E3s are
selected for ubiquitination, conservation of key residues indicates that the ligation mechanism used by
Rsp5 broadly applies to a range of HECT E3s controlling numerous physiological processes (Figure 9).
Following Ub ligation, the HECT domain must reload with Ub, requiring C-lobe rotation to
receive another Ub from E2. This may be stimulated by discharge of Ub from the HECT domain onto the
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Figure 11. Structural view of the ubiquitin transfer cascade for a HECT E3. (A) Top left: Prior structure of E2 (pale
cyan, with active site as sphere)∼Ub (yellow)-NEDD4LHECT (violet, with active site as sphere) (Kamadurai et al.,
2009). Right: new structure of Rsp5WW3-HECT (violet, with active site as sphere) xUb (yellow) xSna3C (green) aligned
over the N-lobes of the NEDD4L and Rsp5 HECT domains. (B) Schematic views of E2-to-E3 Ub transfer and
E3-to-substrate Ub ligation. (C) The different relative orientations of the HECT domain N-lobe with respect to the
HECT domain C-lobe∼Ub are highlighted by superimposing the N-lobes of the E2 (pale cyan, with active site as
sphere)∼Ub (yellow)-NEDD4LHECT (pink, with active site as sphere) (Kamadurai et al., 2009) and Rsp5WW3-HECT (violet,
with active site as sphere) xUb (yellow) xSna3C (green) structures. The HECT domain portions of the two structures
are shown on the right.
DOI: 10.7554/eLife.00828.019

substrate, which would diminish the number of contacts at the junction between the HECT domain
N- and C-lobes, allowing the C-lobe to both face E2 and separate from Ub. Notably, our mutational
data also suggest utilization of a common HECT domain catalytic architecture for both substrate
ligation and Ub chain formation (Figures 2A and 8). Although additional investigation will be required
to reveal how Ub itself is positioned as an acceptor for polyubiquitination, we note that the HECT
C-lobe region we found to interact noncovalently with the donor Ub determines ubiquitin chain
lysine specificity in vitro (Kim and Huibregtse, 2009). We speculate that during polyubiquitination,
the sum of weak interactions between HECT E3 domains and various substrates, adaptors, and regulators, sequentially drives the conformational pathway toward the active form at each step in HECT
E3 cascades.
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Materials and methods
Protein purification
Proteins and peptides used in this work are listed in Table 1. GST-tagged Ub and UbcH5B were
expressed and purified as described (Kamadurai et al., 2009). His-tagged human E1 (Berndsen and
Wolberger, 2011) and Ub were purified by nickel-affinity chromatography and gel filtration. Rsp5WW3-HECT
used in structural studies was nickel-affinity-purified, treated with TEV, and purified by ion exchange. NEDD4,
NEDD4L, Rsp5WW3-HECT, and Rsp5HECT proteins used in the assays were pulled down by affinity chromatography and cleaved from their tags on-column with TEV. All other Rsp5 fragments were further purified
by ion-exchange and gel filtration. All Sna3C proteins were HisMBP fusions, purified by nickel affinity. For
assays, substrates either retained HisMBP or were separated from it by TEV treatment and gel filtration.
Proteins for crosslinking were treated with 10 mM DTT for 30 min and desalted into 25 mM HEPES
7.0, 150 mM NaCl. Rsp5WW3-HECTxUbxSna3C was prepared by reacting single-Cys Rsp5WW3-HECT and Ub
G75C with the Sna3C-maleimide peptide in a molar ratio of 1:2:3, respectively, for 3 min on ice.
The crosslinking reaction was terminated with excess DTT and the products were purified using ion
exchange and sizing chromatography.

Generation of Sna3C peptide with a homobifunctional sulfhydryl crosslinker
Reagents
All reagents used were peptide synthesis grade. All Fmoc amino acids and N,N,N′,N′-tetramethyluronium-hexafluoro-phosphate (HBTU) were obtained from AnaSpec (San Jose, CA). Rink amide

Table 1. Constructs and peptides
Constructs

Description

Rsp5
HisMBP-TEV-Rsp5FL

Rsp5 residues 1–809 were cloned into pRSF-1b with a His6MBP tag, a
poly Asn linker, a TEV site, and a GSGGS linker on the N-terminus

GST-TEV-Rsp5WW1-3-HECT

Rsp5 residues 217–809 cloned into pGEX-4T1 modified to include a
TEV site and a GSGGS linker between GST and Rsp5

GST-TEV- Rsp5WW2-3-HECT

Rsp5 residues 331–809 cloned as above

GST-TEV-Rsp5WW3-HECT

Rsp5 residues 383–809 cloned as above

GST-TEV-Rsp5

Rsp5 residues 432–809 cloned as above

HisMBP-TEV-Rsp5WW3-HECT single-Cys

Rsp5WW3-HECT with the His6MBP-polyN-TEV-GSGGS tag in pRSF-1b and
C455L, C517G, and C721A mutations; retains C777; used in structure studies

NEDD4WW1-4-HECT

NEDD4 residues 165–900 cloned into pGEX-4T1 as above

NEDD4LWW1,3-4-HECT

NEDD4L residues 165–955 but lacking 356–399 (WW2) cloned as above

HECT

Sna3
HisMBP-TEV-Sna3C

Sna3 residues 71–133 with His6MBP-polyN-TEV-GSGGS on the N-terminus

Sna3 -maliemide peptide

Sna3 residues 104–128 chemically synthesized with azidohomoalanine
at position 125, N-terminal acetylation, and C-terminal amidation

Biotin-Sna3C peptide

Same as above but with K125, N-terminal biotinylation, and C-terminal
carboxylation

C

E2
UbcH5B

As described previously (Kamadurai et al., 2009)

E1
Human UBA1

Human UBA1 with a non-cleavable His-tag on the N-terminus expressed
in pET21d

Ub
His-Ub-G75C

His-Ub terminating with G75C; used for structure

His-1Cys Ub

His-Ub with Cys N-terminal of Met1 for fluorescent labeling

GST-TM-2TK-Ub

Human Ub cloned into pGEX2TK (Kamadurai et al., 2009)

DOI: 10.7554/eLife.00828.020
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MBHA resin and 6-chlorobezotriazole (6-chloro-HOBt) were purchased from AAPPTec, Inc (Louisville,
KY). Piperidine, 4-methylmorpholine (NMM), diisopropylethylamine (DIPEA), acetic anhydride, phenol,
triisopropylsilane (TIS), 2,5-dihydroxybenzoic acid (DHB), and thioanisole were obtained from SigmaAldrich (St. Louis, MO). Trifluoroacetic acid (TFA) was purchased from Life Technologies (Carlsbad,
CA). Dimethylformamide (DMF), N-methylpyrrolidone (NMP), and acetonitrile were purchased from
VWR International (Atlanta, GA). Diethyl ether was purchased from Fisher Scientific (Suwanee, GA).
Fmoc-azidohomoalanine was purchased from Bachem (Torrance, CA).

Synthesis of the Sna3C azidopeptide
N3
Acetyl-AQPPAYDEDDEAGADVPLMDN
[M+H]
exact mass: 2656.1222

N
H

QQ-NH2
O

The azidopeptide was synthesized on a fully automated Liberty microwave peptide synthesizer
(CEM Corp., Matthews, NC) at 100 µmol scale using Fmoc-Rink-Amide-Wang resin (loading 0.51
mmol/g). Deprotection was performed in two stages using 20% piperidine in NMP containing 0.1 M
of 6-chloro-HOBt. Stage one of deprotection was for 30 s at 75°C followed by stage two which was for
3 min at 75°C. Coupling was performed using 0.2 mmol amino acids (5 eq., in DMF), 0.3 mmol HBTU
(5 eq.), 0.3 mmol 6-chloro-HOBt (5 eq.), and 0.6 mmol NMM (10 eq.) in NMP for 10 min at 50°C. All amino
acids were double coupled. A capping cycle using 4.75% acetic anhydride and 2.25% DIPEA in NMP
was run after the introduction of each amino acid. Fmoc-azidohomoalanine was coupled similarly using
an external amino acid bottle. After final deprotection, a capping cycle was run to introduce the N-terminal
acetyl group. Cleavage was performed using TFA/phenol/TIS/EDT/thioanisole/water 82.5/2.5/2.5/2.5/5.0/5.0
for 2 hr at room temperature. The cleavage mixture was filtered and precipitated using ice cold diethyl
ether. After centrifugation, the crude peptide was dissolved in water and lyophilized.

Sna3C azidopeptide analysis/quality control
The crude peptide was dissolved in water and analyzed on a Waters 2695 analytical HPLC system
(Waters, Milford, MA) using a C18, 5 μm, 250 × 4.6 mm column (Grace Vydac, Deerfield, IL), over 45 min
with a flow rate of 1 ml/min, and using a gradient of 0–100% B, where buffer A is 0.1% TFA in water, and
buffer B is water/acetonitrile/TFA 80/20/0.1. Detection was at 220 nm. Mass analysis was performed on a
Bruker UltraFlex III TOF/TOF mass spectrometer (Bruker Daltonics, Billerica, MA) using DHB as the matrix.

Sna3C azidopeptide purification
The crude peptide was dissolved in water and purified on a Waters 2695 semi-preparative HPLC
system (Waters) using an XBridge C18, 5 μm, 250 × 10 mm column (Waters) over 45 min with a flow
rate of 4 ml/min, and using a gradient of 0–40% B, where buffer A is 0.1% TFA in water, and buffer B
is 0.1% TFA in acetonitrile. Detection was at 220 nm and 240 nm. Fractions containing the correct mass
were analyzed on the analytical HPLC system, pooled, and lyophilized. The HPLC purity of the purified
azidopeptide was >99%. The correct mass for the azidopeptide was observed at 2656.14 Da for M+H
(calculated mass: 2655.15 Da).

General chemical methods associated with attaching the crosslinker
All commercial reagents were used without further purification and the solvents were dried using the dry
solvent system (Glass Contour Solvent Systems; SG Water, Nashua, NH). All reactions were monitored by
thin-layer chromatography (TLC) carried out on EMD Chemicals silica gel 60-F 254 coated glass plates and
visualized using I2 or UV light (254 nm). Analysis by LC-MS was performed by using an XBridge C18 column
run at 1 ml/min, and using gradient mixtures of (A) water (0.05% TFA) and (B) methanol. Low-resolution
mass spectra (ESI) were collected on a Waters Micromass ZQ in positive-ion mode. Flash-chromatography
was performed on a Biotage SP4 chromatography system using Biotage Flash KP-Sil and KP-NH amine
pre-packed columns. Nuclear magnetic resonance (NMR) spectra were obtained on Bruker Avance II NMR
spectrometer at 400 MHz for 1H-NMR spectra. Chemical shifts (ppm) are reported relative to TMS or
the solvent peak. Signals are designated as follows: s, singlet; d, doublet; dd, doublet of doublet; t, triplet;
q, quadruplet; m, multiplet. Coupling constants (J) are shown in Hertz.
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Preparation of 3,3′-(prop-2-yn-1-ylazanediyl)bis(propan-1-ol)
OH

N

OH

A solution of prop-2-yn-1-amine (0.349 ml, 5.45 mmol) and potassium carbonate (2.26 g, 16.3 mmol)
in MeCN (15 ml) was stirred for 1 hr. 3-Bromopropan-1-ol (2.96 ml, 32.7 mmol) was added to the reaction
mixture, heated to reflux, and stirred for 3 hr. Water (50 ml) was added to the reaction mixture and
extracted with ethyl acetate (3 × 50 ml). The combined organic layers were washed with saturated
brine, dried over Na2SO4, filtered, and concentrated. The crude product was purified by flash column
chromatography (Biotage SP4, 40+M column, eluting with DCM/MeOH, 0–12% gradient) to give
the desired product (303 mg, 33% yield): 1H NMR (400 MHz, CDCl3) δ 3.75 (t, J = 5.7 Hz, 4H), 3.48
(d, J = 2.4 Hz, 2H), 2.74 (t, J = 6.4 Hz, 4H), 2.22 (t, J = 2.4 Hz, 1H), 1.77–1.68 (m, 4H).

Preparation of N,N-bis(3-azidopropyl)prop-2-yn-1-amine

DBU (1.36 ml, 9.01 mmol) and diphenylphosphorylazide (1.94 ml, 9.01 mmol) were added to a
stirring solution of 3,3′-(prop-2-yn-1-ylazanediyl)bis(propan-1-ol) (257 mg, 1.501 mmol) in DMF (6 ml).
The solution was heated to 100°C and stirred for 2 hr. The dark brown reaction mixture was added to
water (20 ml) and extracted with ethyl acetate (3 × 20 ml). The combined organic layers were washed
with saturated brine, dried over Na2SO4, filtered, and concentrated. The crude product was purified by
flash column chromatography (Biotage SP4, 40+M column, eluting with DCM/MeOH, 0–10% gradient)
to give a colorless oil (256 mg, 77% yield): 1H NMR (400 MHz, CDCl3) δ 3.38 (d, J = 2.3 Hz, 2H), 3.35
(t, J = 6.7 Hz, 4H), 2.57 (t, J = 6.8 Hz, 4H), 2.19 (td, J = 2.3, 1.1 Hz, 1H), 1.73 (p, J = 6.8 Hz, 4H).

Preparation of N1-(3-aminopropyl)-N1-(prop-2-yn-1-yl)propane-1,3-diamine

A solution of N,N-bis(3-azidopropyl)prop-2-yn-1-amine (256 mg, 1.16 mmol) and PPh3 (668 mg,
2.55 mmol) in THF/H2O (9:1, 6.7 ml) was stirred overnight. The reaction mixture was concentrated and
purified by flash column chromatography (Biotage SP4, 25+S KP-NH amine column, eluting with DCM/
MeOH, 0–15% gradient) to give a yellow oil (132 mg, 67% yield): 1H NMR (400 MHz, MeOD) δ 3.43
(d, J = 2.2 Hz, 2H), 2.69 (t, J = 7.1 Hz, 4H), 2.61–2.51 (m, 5H), 1.71–1.56 (m, 4H).

Preparation of 1,1′-([prop-2-yn-1-ylazanediyl]bis[propane-3,1-diyl])bis(1Hpyrrole-2,5-dione)

N-Methoxycarbonylmaleimide (155 mg, 1.00 mmol) was added portionwise over the course of 15 min
to a vigorously stirring solution of N1-(3-aminopropyl)-N1-(prop-2-yn-1-yl)propane-1,3-diamine (77 mg,
0.46 mmol) in saturated aqueous NaHCO3 (2.5 ml) at 0°C. The ice bath was removed and the heterogeneous solution was stirred for 1 hr at room temperature. The reaction mixture was diluted with
water (3 ml) and extracted with ethyl acetate (3 × 5 ml). The combined organic layers were washed
with saturated brine, dried over Na2SO4, filtered, and concentrated. The crude product was purified
by flash column chromatography (Biotage SP4, 12+S column, eluting with hexanes/ethyl acetate,
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0–100% gradient) to give a white solid (90 mg, 60% yield): 1H NMR (400 MHz, CDCl3) δ 6.69 (s, 4H),
3.57 (t, J = 7.2 Hz, 4H), 3.38 (s, 2H), 2.47 (t, J = 6.8 Hz, 4H), 2.13 (d, J = 2.3 Hz, 1H), 1.76–1.64 (m, 4H).

Procedure for click chemistry (schematic shown below)
O
O

O

O

N

N
N

N
O

O
N3
Acetyl-AQPPAYDEDDEAGADVPLMDN
[M+H]
exact mass: 2656.1222

N
H

N
QQ-NH2

O

N
N
N
O

CuSO 4, NaAsc,
H2O/tBuOH (2:1)

Acetyl-AQPPAYDEDDEAGADVPLMDN
[M+H]
exact mass: 2985.2597

N
H

O

N
QQ-NH2

O

(+)-Sodium L-ascorbate (120 µmol) was added portionwise to a solution of 1,1′-([prop-2-yn-1ylazanediyl]bis[propane-3,1-diyl])bis(1H-pyrrole-2,5-dione) (120 µmol), the azidopeptide (30 µmol), and
CuSO4 (120 µmol), in H2O/tBuOH (2:1, 20 ml). The solution was stirred for 1 hr and then concentrated.

Purification of the Sna3C peptide with a homobifunctional sulfhydryl
crosslinker
The crude peptide was dissolved in water:acetonitrile (90:10) and purified on a Waters 2695 semipreparative HPLC system using an XBridge C18, 5 μm, 250 × 10 mm column (Waters) over 45 min with
a flow rate of 4 ml/min, and using a gradient of 0–50% B, where buffer A is 0.1% TFA in water, and
buffer B is 0.1% TFA in acetonitrile. Detection was at 220 nm and 240 nm. Fractions containing the
correct mass were analyzed on the analytical HPLC system, pooled, and lyophilized. HPLC purity of the
purified peptide was >99%. The correct mass for the bis-maleimide peptide (peptide for crosslinking)
was observed at 2985.42 Da for M+H (calculated mass: 2984.25 Da).

Crystallization and structure determination
Rsp5WW3-HECTxMBPSna3C (40.8 mg/ml) crystals were grown by hanging drop vapor diffusion in 0.1 M Bis-Tris
propane pH 7.2, 21% wt/vol PEG3350, and 1% wt/vol polypropylene glycol at room temperature, and
cryoprotected in 20% glycerol in the mother liquor. Diffraction data were processed using HKL2000
(Otwinowski and Minor, 1997). PHASER (McCoy et al., 2007) was used to implement molecular
replacement, searching separately for Rsp5 N-lobe, Rsp5 C-lobe, and Ub for the two copies per
asymmetric unit. The WW3 domain and Sna3 peptide were built manually and the model was subjected to multiple rounds of refinement and rebuilding using REFMAC (Murshudov et al., 1997) and
Coot (Table 2; Emsley et al., 2010). The crosslinker and the Sna3 portion near it were not visible in
the map. The final model contains Rsp5 (383–806, chain A; 384–806, chain B), Sna3 (105–112, chain C;
104–117, chain D), and Ub (1–75, chains E and F).

Biochemical assays
Error bars are from triplicates of each experiment. Assays were performed with either radiolabeled
(Kamadurai et al., 2009) or fluorescently labeled Ub and stopped by adding SDS loading buffer, unless specified, and products separated by nonreducing SDS-PAGE and visualized by fluorescent imaging with Typhoon 9200 or autoradiography. DTT-treated controls of either all samples or the final
time-point in a time-course assay confirmed thioester-linked intermediates. To produce fluorescently
labeled ubiquitin, 10× fluorescein-5-maleimide (Anaspec) was reacted with 1Cys Ub for 3 hr at room
temperature. Excess label was quenched with DTT and removed through extensive desalting steps
involving dialysis and PD-10 columns.
Pulse-chase assays to monitor Ub transfer from E2 to Rsp5 to Sna3C or Ub were performed in two
steps. First, UbcH5B (9.1 µM) was reacted with E1 (0.42 µM) and fluorescent Ub (16.7 µM) in 50 mM
Tris 7.6, 300 mM NaCl, 2 mM ATP, 10 mM MgCl2, and 0.04 mg/ml of ovalbumin for 30 min at room temperature or 1 hr at 18°C for 32P-labeled Ub. These first reactions were quenched by diluting fourfold with 25
mM MES 6.5, 100 mM NaCl, 10 mM EDTA and desalting in the same buffer using Zeba Spin Desalting
Columns (Pierce), or diluting fourfold with 25 mM HEPES 7.5, 100 mM NaCl, 25 mM EDTA. Second,
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E2∼Ub was mixed with excess Rsp5 and Sna3C
on ice to initiate a single round of substrate ubiqRsp5WW3-HECTxUbxSna3C
uitination. For Rsp5WW3-HECT mutants and different
Data collection*
fragments of Rsp5, the final concentrations were
Space group
P21
∼0.4 µM E2∼Ub, 2–2.7 µM E3, and 10–10.2 µM
Cell dimensions
Biotin-Sna3C or 200 µM unlabeled Ub. Reactions
were quenched at the indicated times and ana83.046, 78.923, 96.722
   a, b, c (Å)
lyzed by fluorescent imaging or autoradiography
   α, β, γ (°)
90, 101.67, 90
(Storm phosphorimager, GE) of nonreducing SDS†
Resolution (Å)
30–3.1 (3.21–3.1)
PAGE gels. Thioester-linked intermediates were
7.2 (36.1)
Rsym or Rmerge
confirmed by DTT-reduced controls collected by
15.5 (2.0)
I/σI
treating half of the last time-point samples with
Completeness (%)
94.9 (92.7)
100 mM DTT. E3∼Ub conjugates that accumulate
for the defective mutants are thoroughly reduced
Redundancy
3.4 (3.2)
with DTT except for the Lys432Ala/Arg433Ala/
Refinement
Asp434Ala/Arg436Ala and Arg437Ala/Lys438Ala/
Resolution (Å)
Ile440Ala/Tyr441Ala mutants (data not shown).
No. reflections
21,323
Total activity within each lane was determined by
25.1/29.9
Rwork/Rfree
adding all three intensities and was used to estiNo. atoms
mate the relative yield of each species (E2∼Ub,
Rsp5WW3-HECT∼Ub, and Sna3C∼Ub or Ub∼Ub) and
   Protein
7944
scaled with respect to wild-type proteins.
   Ligand/ion
0
For substrate selection assays summarized in
   Water
0
Figure 10C and Figure 10—figure supplement 1,
B-factors
3.6 µM of Rsp5WW1-3-HECT and 6.4 µM of HisMBP   N-lobe (chains A, B)
83.1, 88.2
TEV-Sna3C were used. In this case, the reaction was
   C-lobe (chains A, B)
91.9, 109.7
terminated at 15 s with 100 mM DTT and products
were incubated with TEV for 30 min at room tem   WW3 (chains A, B)
100.0, 100.3
perature to liberate HisMBP. Following quenching
C
   Sna3 (chains C, D)
123.5, 139.3
and separating on SDS gels, each product
   Ub (chains E, F)
124.7, 122.2
(Sna3C∼Ub, Rsp5∼Ub, and HisMBP∼Ub) was quanti   Ligands
NA
fied using ImageQuant TL. Total activity within
   Water
NA
each lane was determined by adding all three
R.m.s. deviations
intensities and was used to estimate the relative
yield of each species. These yields were then
   Bond lengths (Å)
0.009
scaled in proportion to the total activity observed
   Bond angles (°)
1.05
with wild-type proteins to obtain normalized
*Data were collected from single crystals.
product formation.
†Values in parentheses are for highest-resolution shell.
Rapid-quench flow kinetic studies were perDOI: 10.7554/eLife.00828.021
formed at 25°C by reacting 2 µM of E2∼Ub with a
mixture of 4 µM E3 and 30 µM Biotin-Sna3C, using
the KinTeK RQF-3 instrument in 25 mM MES 6.5, 100 mM NaCl, 10 mM EDTA. The reactions were
quenched with SDS gel-loading buffer. E2∼Ub was generated as described above but with 0.5 µM E1
and 10 µM each of UbcH5B and fluorescent Ub. Product separation by SDS-PAGE, visualization by fluorescent scanning, quantification, and normalization within each lane were performed as described for
the substrate selection experiments. The yields were normalized across gels. Error bars are from
triplicate measurements. Rates were obtained by fitting the product vs time data to linear functions
using DeltaGraph (Red Rock Software).
All multiple turnover assays were performed at room temperature in 25 mM HEPES 7.5, 100 mM
NaCl, 5–6 mM MgCl2, 1 mM ATP, 0.2 mg/ml ovalbumin, 100 nM E1, 550 nM E2. The assay described
in Figure 1—figure supplement 1B was performed with Rsp5FL (78 nM) and Rsp5WW1-3-HECT wild-type
and WW mutants (70 nM), 5 µM wild-type or P107A MBP-free Sna3C, and 5 µM fluorescent Ub for
2 min. The substrate ubiquitination assay in Figure 6—figure supplement 1 was performed with
2.5 µM methylated fluorescent Ub, 50 µM Biotin-Sna3C, and 1 µM of the indicated Rsp5WW3-HECT
mutants. Autoubiquitination of NEDD4, NEDD4L, and Rsp5 (Figure 9) was assayed with 1 µM E3 and
2.5 µM fluorescent Ub for 2 min.
Table 2. Data collection and refinement statistics
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Genetic assays for Rsp5-dependent yeast viability
Null rsp5Δ mutant (MATα: leu2-3, 112 ura3-52, his3-Δ200, trp1-Δ901 lys2-801 suc2-Δ9 mel rsp5Δ::HIS3
+ pNTAP416-Rsp5-WT) and rsp5-1 mutant (LHY23: MATa: rsp5-1 leu2-3, 112 ura3-52 bar1) strains
were described previously (Dunn and Hicke, 2001; Oestreich et al., 2007). A previously described
centromere-containing low copy plasmid expressing N-terminally HA tagged wild-type RSP5 (Gajewska
et al., 2001) was converted to a LEU2 plasmid (pPL4333) and used to create the mutants.
For experiments with rsp5Δ null mutants, single colony transformants were grown in minimal media
lacking uracil and leucine to select for plasmids expressing both wild-type and mutant versions of RSP5.
Cells (1 OD) grown to OD600 = 1.0 were resuspended in water, serially diluted 1:10, and spotted onto
SC-Leu plates with or without 1 mg/ml 5-fluoroorotic acid (5-FOA) and grown at 30°C for 2–5 days. For
experiments with rsp5-1 mutants, single colony transformants were similarly serially diluted and spotted
onto YPD and grown for 2–5 days at 30°C or 37°C. To immunoblot for HA-Rsp5, cells were grown to
OD600 = 1.0, centrifuged, incubated with 0.2 M NaOH for 3 min, and resuspended in Laemmli sample
buffer containing 8 M urea. Samples were analyzed by SDS-PAGE followed by immunoblotting using
anti-HA and anti-PGK antibodies.

Structural modeling of the Rsp5WW3-HECTxUbxSna3C catalytic center
We used various modules in the Rosetta3 modeling suite to construct the different features of the
catalytic center; modified versions of the UBQ_E2_thioester and FloppyTail algorithms will be available
in the next Rosetta3 release (currently 3.4) (Leaver-Fay et al., 2011). The UBQ_E2_thioester application generates a thioester-bonded complex and samples torsion angles for the thioester and nearby
residues, including cysteine chi1 and 2, Gly76 phi and pseudo-psi, Gly75 phi and psi, Arg74 phi and
psi, and Leu73 phi and psi (Saha et al., 2011). Additionally, this code was modified to model the location
of terminal Ub acceptor, positioning the NZ of the acceptor lysine collinear with the carbonyl bond and
2.4 Å from the carbonyl carbon on the C-terminal glycine of Ub. Input structures for Rsp5, Ub, and
Sna3 were obtained from the Rsp5WW3-HECTxUbxSna3C co-crystals. Several constraints were placed on
the Ub position derived from the Rsp5WW3-HECTxUbxSna3C three-dimensional structure. We focused on
recovering the β-strand pairing between the Ub tail and the C-lobe active site. To precisely position
the Ub tail, we introduced two angle constraints between the backbones of Ser774 of Rsp5 and Leu74
of Ub. As a preliminary step, we modeled five-residue Ub tails to determine the range of thioester
torsion angles that could accommodate the β-sheet pairing and applied these angles to the starting
pose. Additionally, we decreased the size of the moves on the cysteine chi1 and thioester bond to
obtain more models with optimal geometry; even with this change models with various cysteine chi1
and thioester torsion angles were recovered. We filtered the subsequent models on constraint energy,
RMSD to Ub, and visual inspection, and selected the top five models.
For these five models, we used the FloppyTail application to sample possible conformations of the
Sna3 substrate (Kleiger et al., 2009). Constraints were placed on the location of the PPXY motif. Residues
115–124, between the PPXY motif and the acceptor lysine, were allowed to sample backbone torsion
angles, and the models were filtered by lowest energy and RMSD to the crystal PPXY motif.
To ascertain possible N-lobe loop conformations for residues 491–495, we grafted a homologous
segment of NEDD4L (PDB 3JW0) containing residues 630–645, which correspond to residues 483–505
on Rsp5. We used a two-step protocol to close and refine the loop. First, we used perturb KIC to close
the loop in the absence of the Sna3 peptide and substituted the corrected amino acid identities that
varied in the grafted NEDD4L loop. We allowed backbone sampling for residues 488–498, and selected
the lowest energy closed loop; about 5% of the models had successfully closed N-lobe loops. Next,
we refined the loop in the presence of the Sna3C peptide, both with and without a 3 Å distance constraint between the acceptor lysine and Asp495 side chain. Although the loop could adopt multiple
orientations that could bring these residues in close proximity, without this constraint Rosetta favored
orientations that placed Asp495 more distant from the acceptor lysine. We examined the models
scoring in the 90th percentile and found that about half of them had a very similar loop orientation and
choose a representative structure from this set.
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